Programme (nur in Englisch)

Funded projects
1,320+
Men's Health Partners
20
Countries
20
We work closely with our global men's health partners to ensure collaboration, transparency and accountability for every project we fund. We monitor this through report cards which detail what we seek to achieve, key measures and the impact.
Prostate Cancer
"Together with the brightest minds in research, we aim to achieve significant breakthroughs in the hope of beating prostate cancer. Our disruptive funding approach identifies revolutionary ways to accelerate health outcomes by creating strong, global collaborative teams." Dr. Colleen Nelson, Global Scientific Chair.
Men's Health
"One Mo can help change the face of men’s health through the powerful conversations created globally during Movember. Men have the chance to confidently discuss men’s health with people around them, resulting in men taking action early, helping change and save lives." Paul Villanti, Executive Director, Programmes
Mental health and suicide prevention
“The number of men taking their own lives around the world is one of the biggest challenges of our time. Movember is working to ensure all men and boys look after their mental health and are comfortable to seek help when they’re struggling.”
Brendan Maher, Global Director, Mental Health and Suicide Prevention.
Testicular Cancer
“Despite being the 2nd most common cancer in young men, testicular cancer is often a forgotten cancer due to early detection and treatment. Our projects look at underinvested areas such as improving access to healthcare services and treatment options for relapse” Paul Villanti, Executive Director, Programmes.

GAP3 Prostate Cancer Active Surveillance

Movember Funding to Date

Global funding AUD equivalent 5,920,449

What we seek to achieve

GAP3 unites leading research teams in active surveillance to build a global database, helping clinicians and patients make informed decisions on monitoring low to intermediate risk prostate cancer.

Country
United States
Implemented by
The Movember Foundation
Project start date
August 2013
Project Status
Completed July 2016

About the project

Doctors and researchers worldwide are working together to better understand how to manage low-risk prostate cancer without immediately turning to treatments. This approach, known as active surveillance (AS), involves carefully monitoring the cancer over time for signs that it could be spreading.


The GAP3 project, which began in 2015, has united 30 doctors and researchers representing 16 countries. Together, they've created the worlds largest database of men on AS, containing information from 25,000 patients!

By examining this data, GAP3 aims to increase understanding of AS, reducing the number of men who switch to active treatments when their cancer isn't spreading. This approach helps protect men from unnecessary treatments and side effects, ultimately improving their quality of life.

The team has published their findings in 20 peer-reviewed journals. These insights help doctors make better decisions about who can start AS, how to monitor the disease, and when to consider more active treatments.

>
Page 1 of 31